光感受器细胞与视网膜色素上皮参与糖尿病视网膜病变的发生
糖尿病视网膜病变长期被视为血管疾病,但神经视网膜也出现异常,且血管与神经研究长期割裂。本综述汇总证据表明,糖尿病时外视网膜发生改变,光感受器与视网膜色素上皮参与早期视网膜血管改变,相关分子机制被讨论。外视网膜的糖尿病性改变是抑制糖尿病视网膜病变的新治疗靶点。
要点
- 糖尿病视网膜病变不仅累及血管,神经视网膜亦出现异常。
- 光感受器与视网膜色素上皮参与早期血管病变的发生。
- 外视网膜改变是抑制糖尿病视网膜病变的潜在治疗靶点。
核心结论
- 糖尿病引起的外视网膜改变是抑制糖尿病视网膜病变的新治疗靶点。
研究设计与样本
- 综述,总结糖尿病时外视网膜改变及光感受器与视网膜色素上皮参与早期视网膜血管改变的证据。
主要发现
- 糖尿病时外视网膜发生改变。
- 光感受器与视网膜色素上皮参与糖尿病视网膜病变早期阶段的视网膜血管改变。
- 血管与神经异常研究长期分离,未整合为包含神经与血管成分的糖尿病视网膜病变综合观点。
临床怎么用
- 可将外视网膜的糖尿病性改变视为抑制糖尿病视网膜病变的潜在治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetic retinopathy (DR) is a leading cause of blindness. It has long been regarded as vascular disease, but work in the past years has shown abnormalities also in the neural retina. Unfortunately, research on the vascular and neural abnormalities have remained largely separate, instead of being integrated into a comprehensive view of DR that includes both the neural and vascular components. Recent evidence suggests that the most predominant neural cell in the retina (photoreceptors) and the adjacent retinal pigment epithelium (RPE) play an important role in the development of vascular lesions characteristic of DR. This review summarizes evidence that the outer retina is altered in diabetes, and that photoreceptors and RPE contribute to retinal vascular alterations in the early stages of the retinopathy. The possible molecular mechanisms by which cells of the outer retina might contribute to retinal vascular damage in diabetes also are discussed. Diabetes-induced alterations in the outer retina represent a novel therapeutic target to inhibit DR.
引用
- Tonade D, Kern TS. Photoreceptor cells and RPE contribute to the development of diabetic retinopathy. Prog Retin Eye Res. 2020. PMID: 33188897. doi:10.1016/j.preteyeres.2020.100919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。